Systemic chemotherapy and chemoradiotherapy for advanced pancreatic cancer

Ueno, H.; Okusaka, T.

Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(3): 357-363

2012


ISSN/ISBN: 0385-0684
PMID: 22421761
Document Number: 657855
Currently, we are able to use S-1 with gemcitabine and erlotinib, as well as gemcitabine alone, as first-line therapy for advanced pancreatic cancer. In addition, a clinical trial of FOLFIRINOX is underway in Japan. On the other hand, chemoradiotherapy is considered to be one of the treatments of choice for locally advanced pancreatic cancer. This review summarizes current knowledge about non-surgical treatment for advanced pancreatic cancer, mainly based on the results of recent clinical trials.

Document emailed within 1 workday
Secure & encrypted payments